slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 231,961-231,990
Pages 10,126
Rows per page 30
Component
231,961-231,990 of 303,780
04
Slide contains four distinct charts: one bar chart for voucher requests, one stacked bar for cash position, and one stacked bar for cash use.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations 1 hit
05
The slide emphasizes operational reality over theoretical development.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations 1 hit
06
The slide highlights the 'Battery Electric 2.0' initiative and provides a competitive breakdown of HVIP voucher requests.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
08
The slide uses a circular process flow to illustrate the 'Build, Repeat' strategy.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
10
The slide presents two distinct financial tables side-by-side with qualitative commentary for each.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The slide uses a stacked bar chart to decompose unit costs into variable, fixed, and accrual components.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations Beat · Satisfaction1 hit
13
The table includes truck deliveries, revenue, gross margin, R&D, SG&A, stock-based compensation, and CapEx.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations 1 hit
14
Nikola | Results Presentation Deck | 18 slidesNikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations 1 hit
15
Includes a footnote regarding regulatory and legal matters.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations 1 hit
16
Includes a footnote regarding regulatory and legal matters.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations 1 hit
17
The table reconciles GAAP cash flow components to the non-GAAP 'Adjusted free cash flow' metric.Nikola | Results Presentation Deck | 18 slides · Nikola
Conference presentation Investor relations 1 hit
01
Nuvalent | Investor Presentation Deck | 42 slidesNuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
02
Nuvalent | Investor Presentation Deck | 42 slidesNuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
05
The slide uses a timeline-based structure to demonstrate operational momentum.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
06
The slide uses a timeline to show the progression from global strategy execution to product approval, complemented by a list of 2024 milestones.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
11
The slide uses a bar chart to segment the $3.1B market into specific drugs and categories.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Market SizeLoop · Pattern Hunter1 hit
12
The slide uses a sidebar 'AT A GLANCE' to summarize key product attributes.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
13
The slide uses a timeline-based framework to map clinical stages (1L, 2L, 3L+) against standard therapies and unmet needs.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
14
The slide uses a matrix-like structure to compare drug generations against clinical outcomes.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
15
The slide uses a split-screen layout to contrast in vitro potency (dot plot) with in vivo efficacy (bar chart).Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
17
Includes detailed patient enrollment table by dose cohort and trial objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
18
Data cut-off: 8 Aug 2023. Includes detailed breakdown of prior ALK TKI lines and specific mutations.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
Data from ALKOVE-1 Phase 1 trial, presented at AACR-NCI-EORTC 2023.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
20
The slide uses a standard oncology 'swimmer' or 'waterfall' plot format to demonstrate drug efficacy across different patient cohorts.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
21
Swimmer plot showing patient-level treatment duration with ongoing status and response markers.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
22
Includes two patient case studies with MRI scans showing baseline vs follow-up results.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
23
Data cut-off: 8 Aug 2023. Source: Lin J.J. et al., AACR-NCI-EORTC 2023.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
24
The chart shows pharmacokinetic data across five dose cohorts, demonstrating that the 150mg dose consistently stays above the predicted CNS efficacy thresholds.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
26
Includes a detailed table of patient cohorts and study objectives.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
27
The slide uses a sidebar 'AT A GLANCE' to summarize key clinical and regulatory status.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit